The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

20 articles for W Ye


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Part 1: Notch-sparing¿-secretase inhibitors: The identification of novel naphthyl and benzofuranyl amide analogs.EBI
Harvard Medical School
Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis.EBI
Genentech
Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors.EBI
Genentech
Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization.EBI
Genentech
Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.EBI
China Pharmaceutical University
Cernuosides A and B, two sucrase inhibitors from Pulsatilla cernua.EBI
China Pharmaceutical University
Design, Synthesis, and Biological Evaluation of Pierardine Derivatives as Novel Brain-Penetrant and In Vivo Potent NMDAR-GluN2B Antagonists for Ischemic Stroke Treatment.EBI
Anhui University of Chinese Medicine
Design, synthesis, and analgesia evaluation of novel Transient Receptor Potential Vanilloid 1 (TRPV1) agonists modified from Cannabidiol (CBD).EBI
Shanghai University of Traditional Chinese Medicine
The SAR and action mechanisms of autophagy inhibitors that eliminate drug resistance.EBI
Guangzhou University of Chinese Medicine
Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances.EBI
Guangzhou University of Chinese Medicine
Discovery of Benzocyclic Sulfone Derivatives as Potent CXCR2 Antagonists for Cancer Immunotherapy.EBI
Peking Union Medical College
Discovery of novel trimethoxyphenylbenzo[d]oxazoles as dual tubulin/PDE4 inhibitors capable of inducing apoptosis at G2/M phase arrest in glioma and lung cancer cells.EBI
Southern Medical University
Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis.EBI
China Pharmaceutical University
Design, synthesis and evaluation of 1-benzyl-1H-imidazole-5-carboxamide derivatives as potent TGR5 agonists.EBI
Henan University
Design and synthesis of α-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation.EBI
Hunan Agricultural University
Matrix metalloproteinase inhibitors: a structure-activity study.EBI
Glycomed
Part 2. Notch-sparing γ-secretase inhibitors: The study of novel γ-amino naphthyl alcohols.EBI
Harvard Medical School
Benzimidazolone derived inhibitors of BCL6BDB
Cancer Research Technology
Methods of treatment using modulators of SIRT2BDB
Cornell University